Demographic and epidemiological characteristics of Covid-19 disease in Helios-Hospital and determinants of clinical course
Recruiting
- Conditions
- Covid-19 disease
- Registration Number
- DRKS00021161
- Lead Sponsor
- Abteilung für Krankenhaushygiene
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 1000
Inclusion Criteria
all patients who were diagnosed with SARS-CoV-2 after laboratory confirmation and who had been admitted to hospital since 15.02.20
Exclusion Criteria
Covid-19 negative Patients
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary endpoints are composed of admission to an intensive care unit (ICU), tracheal intubation or death.
- Secondary Outcome Measures
Name Time Method The secondary endpoints are : length of stay at the ICU and utilization of ICU capacity
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie severe Covid-19 disease progression in DRKS00021161 observational study?
How do demographic factors influence SARS-CoV-2 clinical outcomes in Helios-Hospital cohort analysis?
What biomarkers correlate with differential susceptibility to SARS-CoV-2 in DRKS00021161 patient data?
Are there specific comorbidities associated with increased mortality risk in DRKS00021161 Covid-19 patients?
What epidemiological patterns emerge from DRKS00021161 regarding age-related severity of SARS-CoV-2 infection?